Cargando…
2482. Impact of a Recombinant Zoster Vaccine on Quality of Life: Data from a Randomized, Placebo-Controlled, Phase 3 Trial in Adult Hematopoietic Stem Cell Transplant Recipients
BACKGROUND: Herpes zoster (HZ) and its complications can have a substantial impact on patients’ quality of life (QoL), particularly in immunocompromised patients. The vaccine efficacy (VE) of an adjuvanted recombinant zoster vaccine (RZV) was studied in a randomized, placebo-controlled, phase 3 stud...
Autores principales: | Curran, Desmond, Anagnostopoulos, Achilles, Barista, Ibrahim, Bastidas, Adriana, Chandrasekar, Pranatharthi, Dickinson, Michael, Heras, Inmaculada, Idrissi, Mohamed El, Matthews, Sean, Milliken, Samuel, Coll, Jorge Monserrat, Matilla, Maria Belen Navarro, Oostvogels, Lidia, Quiel, Dimas, Rowley, Scott, Sabry, Waleed, Selleslag, Dominik, Szer, Jeff, Theunissen, Koen, Yegin, Zeynep Arzu, Yeh, Su-Peng, Young, Jo-Anne, Zaja, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253678/ http://dx.doi.org/10.1093/ofid/ofy210.2135 |
Ejemplares similares
-
1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
por: Pizzuto, Matteo Samuele, et al.
Publicado: (2020) -
2482 Reward-based learning as a function of the severity of substance abuse risk in drug-naïve youth
por: Parvaz, Muhammad A., et al.
Publicado: (2018) -
631. Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness
por: Sager, Jennifer, et al.
Publicado: (2020) -
2482. Cross Validation of Surgical Procedure Data in National Healthcare Safety Network vs Hospital Discharge Data
por: Sato, Yoran (Lana), et al.
Publicado: (2023) -
PB2482: ROXADUSTAT SUPPRESSES ADIPOGENESIS IN HUMAN BMMSC AND PROMOTES EPO PRODUCTION VIA REGULATION OF HIF SIGNALING PATHWAYS
por: Zhang, Jing, et al.
Publicado: (2023)